Sensei Biotherapeutics Inc. (SNSE)
$25.96
$-10.21
(-28.23%)
As on 17-Jul-2026 09:30EDT
Market cap
$19 Mln
Revenue (TTM)
$-5 Mln
P/E Ratio
--
P/B Ratio
4.9
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.7 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
1.4
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-141.6
-
Face value
--
-
Shares outstanding
1,341,941
6 Years Aggregate
CFO
$-137.90 Mln
EBITDA
$-164.34 Mln
Net Profit
$-173.04 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sensei Biotherapeutics (SNSE)
| 143.3 | 78.7 | -11.2 | 216.4 | 0.2 | -29.1 | -- |
|
BSE Sensex*
| -11.9 | -4.9 | 1.0 | -8.0 | 3.9 | 5.1 | 10.0 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Sensei Biotherapeutics (SNSE)
| 8.9 | -29.0 | -53.6 | -74.3 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Sensei Biotherapeutics (SNSE)
|
26.0 | 18.6 | -4.9 | -195.5 | 4,030.5 | -204.2 | -- | 4.9 |
| 82.6 | 12,161.6 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.2 | |
| 74.1 | 10,109.8 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.5 | |
| 58.3 | 14,621.6 | 2,435.9 | 860.6 | 31.0 | 43 | 18.6 | 7.9 | |
| 107.4 | 12,506.3 | 1,663.7 | 413.6 | 36.3 | 430 | 32.3 | 86.7 | |
| 348.1 | 10,603.5 | 440.5 | 241.5 | 33.4 | 18.7 | 44.9 | 8.1 | |
| 115.4 | 9,761.1 | 105.0 | -299.7 | -227.2 | -19.4 | -- | 6.5 | |
| 546.7 | 12,501.2 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 23.9 | |
| 586.3 | 16,503.9 | 2,782.3 | 491.5 | 21.1 | 110.1 | 34.7 | 38.2 | |
| 124.0 | 9,808.7 | 0.0 | -450.1 | -- | -44.6 | -- | 8.4 |
Shareholding Pattern
View DetailsAbout Sensei Biotherapeutics (SNSE)
Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in... development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company's pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early development stages for the treatment of solid tumors, as well as SNS-201 is a bispecific antibody targeting CD28. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland. Read more
-
President, CEO & Director
Mr. John K. Celebi M.B.A.
-
President, CEO & Director
Mr. John K. Celebi M.B.A.
-
Headquarters
Rockville, MD
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Sensei Biotherapeutics (SNSE)
What is the current share price of Sensei Biotherapeutics Inc (SNSE) Today?
The share price of Sensei Biotherapeutics Inc (SNSE) is $25.96 (NASDAQ) as of 17-Jul-2026 09:30 EDT. Sensei Biotherapeutics Inc (SNSE) has given a return of 0.21% in the last 3 years.
What is the current PB & PE ratio of Sensei Biotherapeutics Inc (SNSE)?
Since, TTM earnings of Sensei Biotherapeutics Inc (SNSE) is negative, P/E ratio is not available.
The P/B ratio of Sensei Biotherapeutics Inc (SNSE) is 4.86 times as on 17-Jul-2026, a 9 discount to its peers’ median range of 5.33 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.64 |
0.72 |
2024 |
-0.41 |
0.32 |
2023 |
-0.51 |
0.27 |
2022 |
-0.94 |
0.44 |
2021 |
-4.82 |
1.21 |
What is the 52 Week High and Low of Sensei Biotherapeutics Inc (SNSE)?
The 52-week high and low of Sensei Biotherapeutics Inc (SNSE) are Rs 36.93 and Rs 6.33 as of 10-Sep-2026.
What is the market cap of Sensei Biotherapeutics Inc (SNSE)?
Sensei Biotherapeutics Inc (SNSE) has a market capitalisation of $ 19 Mln as on 17-Jul-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Sensei Biotherapeutics Inc (SNSE)?
Before investing in Sensei Biotherapeutics Inc (SNSE), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.